Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin

Sodium glucose co‐transporter 2 (SGLT2) inhibitors have been associated with increased serum ketone body levels in patients with type 2 diabetes mellitus (T2DM). In the present analysis we evaluated serum ketone body levels and variability in 1278 Japanese patients with T2DM treated with canaglifloz...

Descripción completa

Detalles Bibliográficos
Autores principales: Polidori, David, Iijima, Hiroaki, Goda, Maki, Maruyama, Nobuko, Inagaki, Nobuya, Crawford, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947648/
https://www.ncbi.nlm.nih.gov/pubmed/29341404
http://dx.doi.org/10.1111/dom.13224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947648/
https://www.ncbi.nlm.nih.gov/pubmed/29341404
http://dx.doi.org/10.1111/dom.13224

Ejemplares similares